Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 208

The DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.

GPR43/FFA2: physiopathological relevance and therapeutic prospects

Open access
Bindels, Laure B., Dewulf, Evelyne M., Delzenne, Nathalie M.·2013·Trends in Pharmacological Sciences
DOI 10.1016/j.tips.2013.02.002
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.tips.2013.02.002

Cites

10 of 10 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 10 references

Research works printed but not linked: 47

  1. Shoichet, 2012, Structure-based drug screening for G-protein-coupled receptors, Trends Pharmacol. Sci., 33, 268, 10.1016/j.tips.2012.03.007 · DOI · Paper page
  2. Stoddart, 2008, International Union of Pharmacology. LXXI. Free fatty acid receptors FFA1, -2, and -3: pharmacology and pathophysiological functions, Pharmacol. Rev., 60, 405, 10.1124/pr.108.00802 · DOI · Paper page
  3. Nilsson, 2003, Identification of a free fatty acid receptor, FFA2R, expressed on leukocytes and activated by short-chain fatty acids, Biochem. Biophys. Res. Commun., 303, 1047, 10.1016/S0006-291X(03)00488-1 · DOI · Paper page
  4. Roberfroid, 2010, Prebiotic effects: metabolic and health benefits, Br. J. Nutr., 104, S1, 10.1017/S0007114510003363 · DOI · Paper page
  5. Ulven, 2012, Short-chain free fatty acid receptors FFA2/GPR43 and FFA3/GPR41 as new potential therapeutic targets, Front. Endocrinol. (Lausanne), 3, 111, 10.3389/fendo.2012.00111 · DOI · Paper page
  6. Blad, 2012, G protein-coupled receptors for energy metabolites as new therapeutic targets, Nat. Rev. Drug Discov., 11, 603, 10.1038/nrd3777 · DOI · Paper page
  7. Talukdar, 2011, Targeting GPR120 and other fatty acid-sensing GPCRs ameliorates insulin resistance and inflammatory diseases, Trends Pharmacol. Sci., 32, 543, 10.1016/j.tips.2011.04.004 · DOI · Paper page
  8. Vinolo, 2011, SCFAs induce mouse neutrophil chemotaxis through the GPR43 receptor, PLoS ONE, 6, e21205, 10.1371/journal.pone.0021205 · DOI · Paper page
  9. Siavoshian, 2000, Butyrate and trichostatin A effects on the proliferation/differentiation of human intestinal epithelial cells: induction of cyclin D3 and p21 expression, Gut, 46, 507, 10.1136/gut.46.4.507 · DOI · Paper page
  10. Bjursell, 2011, Improved glucose control and reduced body fat mass in free fatty acid receptor 2-deficient mice fed a high-fat diet, Am. J. Physiol. Endocrinol. Metab., 300, E211, 10.1152/ajpendo.00229.2010 · DOI · Paper page
  11. Stoddart, 2008, Conserved polar residues in transmembrane domains V, VI, and VII of free fatty acid receptor 2 and free fatty acid receptor 3 are required for the binding and function of short chain fatty acids, J. Biol. Chem., 283, 32913, 10.1074/jbc.M805601200 · DOI
  12. Swaminath, 2010, Allosteric rescuing of loss-of-function FFAR2 mutations, FEBS Lett., 584, 4208, 10.1016/j.febslet.2010.09.007 · DOI
  13. Schmidt, 2011, Selective orthosteric free fatty acid receptor 2 (FFA2) agonists: identification of the structural and chemical requirements for selective activation of FFA2 versus FFA3, J. Biol. Chem., 286, 10628, 10.1074/jbc.M110.210872 · DOI
  14. Smith, 2011, Extracellular loop 2 of the free fatty acid receptor 2 mediates allosterism of a phenylacetamide ago-allosteric modulator, Mol. Pharmacol., 80, 163, 10.1124/mol.110.070789 · DOI
  15. Swaminath, 2011, Mutational analysis of G-protein coupled receptor–FFA2, Biochem. Biophys. Res. Commun., 405, 122, 10.1016/j.bbrc.2010.12.139 · doi:10.1016/j.bbrc.2010.12.139
  16. Lee, 2008, Identification and functional characterization of allosteric agonists for the G protein-coupled receptor FFA2, Mol. Pharmacol., 74, 1599, 10.1124/mol.108.049536 · DOI
  17. Wang, 2010, The first synthetic agonists of FFA2: discovery and SAR of phenylacetamides as allosteric modulators, Bioorg. Med. Chem. Lett., 20, 493, 10.1016/j.bmcl.2009.11.112 · DOI
  18. Bindels, 2012, Gut microbiota-derived propionate reduces cancer cell proliferation in the liver, Br. J. Cancer, 107, 1337, 10.1038/bjc.2012.409 · DOI · Paper page
  19. Hudson, 2012, Extracellular ionic locks determine variation in constitutive activity and ligand potency between species orthologs of the free fatty acid receptors FFA2 and FFA3, J. Biol. Chem., 287, 41195, 10.1074/jbc.M112.396259 · DOI
  20. Hudson, 2012, Chemically engineering ligand selectivity at the free fatty acid receptor 2 based on pharmacological variation between species orthologs, FASEB J., 26, 4951, 10.1096/fj.12-213314 · DOI
  21. Hudson, 2011, Experimental challenges to targeting poorly characterized GPCRs: uncovering the therapeutic potential for free fatty acid receptors, Adv. Pharmacol., 62, 175, 10.1016/B978-0-12-385952-5.00006-3 · DOI
  22. Hong, 2005, Acetate and propionate short chain fatty acids stimulate adipogenesis via GPCR43, Endocrinology, 146, 5092, 10.1210/en.2005-0545 · DOI · Paper page
  23. Ge, 2008, Activation of G protein-coupled receptor 43 in adipocytes leads to inhibition of lipolysis and suppression of plasma free fatty acids, Endocrinology, 149, 4519, 10.1210/en.2008-0059 · DOI · Paper page
  24. Dewulf, 2011, Inulin-type fructans with prebiotic properties counteract GPR43 overexpression and PPARγ-related adipogenesis in the white adipose tissue of high-fat diet-fed mice, J. Nutr. Biochem., 22, 712, 10.1016/j.jnutbio.2010.05.009 · DOI · Paper page
  25. Dewulf, 2013, Evaluation of the relationship between GPR43 and adiposity in human, Nutr. Metab. (Lond.), 10, 11, 10.1186/1743-7075-10-11 · DOI
  26. Xiong, 2004, Short-chain fatty acids stimulate leptin production in adipocytes through the G protein-coupled receptor GPR41, Proc. Natl. Acad. Sci. U.S.A., 101, 1045, 10.1073/pnas.2637002100 · DOI · Paper page
  27. Zaibi, 2010, Roles of GPR41 and GPR43 in leptin secretory responses of murine adipocytes to short chain fatty acids, FEBS Lett., 584, 2381, 10.1016/j.febslet.2010.04.027 · DOI · Paper page
  28. Tazoe, 2008, Roles of short-chain fatty acids receptors, GPR41 and GPR43 on colonic functions, J. Physiol. Pharmacol., 59, 251
  29. Karaki, 2006, Short-chain fatty acid receptor, GPR43, is expressed by enteroendocrine cells and mucosal mast cells in rat intestine, Cell Tissue Res., 324, 353, 10.1007/s00441-005-0140-x · DOI · Paper page
  30. Karaki, 2008, Expression of the short-chain fatty acid receptor, GPR43, in the human colon, J. Mol. Histol., 39, 135, 10.1007/s10735-007-9145-y · DOI · Paper page
  31. Dass, 2007, The relationship between the effects of short-chain fatty acids on intestinal motility in vitro and GPR43 receptor activation, Neurogastroenterol. Motil., 19, 66, 10.1111/j.1365-2982.2006.00853.x · DOI · Paper page
  32. Donnelly, 2012, The structure and function of the glucagon-like peptide-1 receptor and its ligands, Br. J. Pharmacol., 166, 27, 10.1111/j.1476-5381.2011.01687.x · DOI · Paper page
  33. Kaji, 2011, Density distribution of free fatty acid receptor 2 (FFA2)-expressing and GLP-1-producing enteroendocrine L cells in human and rat lower intestine, and increased cell numbers after ingestion of fructo-oligosaccharide, J. Mol. Histol., 42, 27, 10.1007/s10735-010-9304-4 · DOI
  34. Delzenne, 2011, Interaction between obesity and the gut microbiota: relevance in nutrition, Annu. Rev. Nutr., 31, 15, 10.1146/annurev-nutr-072610-145146 · DOI · Paper page
  35. Cox, 2009, Short-chain fatty acids act as anti-inflammatory mediators by regulating prostaglandin E2 and cytokines, World J. Gastroenterol., 15, 5549, 10.3748/wjg.15.5549 · DOI · Paper page
  36. Vinolo, 2011, Regulation of inflammation by short chain fatty acids, Nutrients, 3, 858, 10.3390/nu3100858 · DOI · Paper page
  37. Sina, 2009, G protein-coupled receptor 43 is essential for neutrophil recruitment during intestinal inflammation, J. Immunol., 183, 7514, 10.4049/jimmunol.0900063 · DOI · Paper page
  38. Koleva, 2012, Inulin and fructo-oligosaccharides have divergent effects on colitis and commensal microbiota in HLA-B27 transgenic rats, Br. J. Nutr., 108, 1633, 10.1017/S0007114511007203 · DOI
  39. Cani, 2007, Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia, Diabetologia, 50, 2374, 10.1007/s00125-007-0791-0 · DOI · Paper page
  40. Rowland, 2009, The role of the gastrointestinal microbiota in colorectal cancer, Curr. Pharm. Des., 15, 1524, 10.2174/138161209788168191 · DOI
  41. Tang, 2011, Short-chain fatty acids induced autophagy serves as an adaptive strategy for retarding mitochondria-mediated apoptotic cell death, Cell Death Differ., 18, 602, 10.1038/cdd.2010.117 · DOI · Paper page
  42. Tang, 2011, G-protein-coupled receptor for short-chain fatty acids suppresses colon cancer, Int. J. Cancer, 128, 847, 10.1002/ijc.25638 · DOI · Paper page
  43. Hatanaka, 2010, Identification of transforming activity of free fatty acid receptor 2 by retroviral expression screening, Cancer Sci., 101, 54, 10.1111/j.1349-7006.2009.01348.x · DOI
  44. Qin, 2010, A human gut microbial gene catalogue established by metagenomic sequencing, Nature, 464, 59, 10.1038/nature08821 · DOI · Paper page
  45. Everard, 2011, Responses of gut microbiota and glucose and lipid metabolism to prebiotics in genetic obese and diet-induced leptin-resistant mice, Diabetes, 60, 2775, 10.2337/db11-0227 · DOI · Paper page
  46. Dewulf, E.M. et al. Insight into the prebiotic concept: lessons from an exploratory, double blind intervention study with inulin-type fructans in obese women. Gut, (in press) http://dx.doi.org/10.1136/gutjnl-2012-303304 · DOI · Paper page
  47. Tarini, 2010, The fermentable fibre inulin increases postprandial serum short-chain fatty acids and reduces free-fatty acids and ghrelin in healthy subjects, Appl. Physiol. Nutr. Metab., 35, 9, 10.1139/H09-119 · DOI · Paper page

Cited by

See all 208

Metadata

Authors
Bindels, L. B., Dewulf, E. M., & Delzenne, N. M.
Venue
Trends in Pharmacological Sciences
Publisher
Elsevier BV
Published
2013-04
Volume
34
Issue
4
Pages
226-232
ISSN
0165-6147 (ISSN-L)
DOI
10.1016/j.tips.2013.02.002
OpenAlex
W2045729780
Cited by
208
References
10
FWCI
1.21
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: GPR43/FFA2: physiopathological relevance and therapeutic prospects. https://app.cochat.ai/papers/10.1016/j.tips.2013.02.002
The paper
Bindels, L. B., Dewulf, E. M., & Delzenne, N. M. (2013). GPR43/FFA2: physiopathological relevance and therapeutic prospects. Trends in Pharmacological Sciences. https://doi.org/10.1016/j.tips.2013.02.002

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.